SUSCEPTIBILITIES OF 123 XANTHOMONAS-MALTOPHILIA STRAINS TO CLINAFLOXACIN, PD-131628, PD-138312, PD-140248, CIPROFLOXACIN, AND OFLOXACIN

被引:26
作者
PANKUCH, GA
JACOBS, MR
APPELBAUM, PC
机构
[1] HERSHEY MED CTR,DEPT PATHOL CLIN MICROBIOL,HERSHEY,PA 17033
[2] CASE WESTERN RESERVE UNIV,DEPT PATHOL CLIN MICROBIOL,CLEVELAND,OH 44106
关键词
D O I
10.1128/AAC.38.2.369
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The susceptibilities of 123 clinically isolated strains of Xanthomonas maltophilia to six fluoroquinolones (clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin) were examined py microdilution MIC methodology. Clinafloxacin and PD 131628 were the most active compounds tested (MICs for 50% of the strains tested [MIC(50)s] of 0.5 and 1.0 mu g/ml and MIC(90)s of 2.0 and 4.0 mu g/ml, respectively). PD 138312, PD 140248, ciprofloxacin, and ofloxacin were less active, with MIC(50)s ranging from 4.0 to 8.0 mu g/ml and MIC(90)s of 16.0 mu g/ml for all four compounds. Only clinafloxacin and PD 131628 were active against ciprofloxacin-resistant strains, with MIC(50)s of 0.5 and 1.0 mu g/ml and MIC(90)s of 2.0 and 4.0 mu g/ml, respectively.
引用
收藏
页码:369 / 370
页数:2
相关论文
共 17 条
[1]   CIPROFLOXACIN DISK SUSCEPTIBILITY TESTS - INTERPRETIVE ZONE SIZE STANDARDS FOR 5-MU-G DISKS [J].
BARRY, AL ;
FASS, RJ ;
ANHALT, JP ;
NEU, HC ;
THORNSBERRY, C ;
TILTON, RC ;
PAINTER, BG ;
WASHINGTON, JA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 21 (06) :880-883
[2]  
BIEN P, 1993, COMMUNICATION
[3]   EFFECT OF MEDIA COMPOSITION ON THE SUSCEPTIBILITY OF XANTHOMONAS-MALTOPHILIA TO BETA-LACTAM ANTIBIOTICS [J].
BONFIGLIO, G ;
LIVERMORE, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 (06) :837-842
[4]   SYNERGISTIC INTERACTIONS OF CIPROFLOXACIN AND EXTENDED-SPECTRUM BETA-LACTAMS OR AMINOGLYCOSIDES AGAINST MULTIPLY DRUG-RESISTANT PSEUDOMONAS-MALTOPHILIA [J].
CHOW, AW ;
WONG, J ;
BARTLETT, KH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) :782-784
[5]   INVITRO ANTIBACTERIAL ACTIVITIES OF THE FLUOROQUINOLONES PD-117596, PD-124816, AND PD-127391 [J].
COHEN, MA ;
HUBAND, MD ;
MAILLOUX, GB ;
YODER, SL ;
ROLAND, GE ;
HEIFETZ, CL .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1991, 14 (03) :245-258
[6]   INVITRO ANTIBACTERIAL ACTIVITIES OF PD-131628, A NEW 1,8-NAPHTHYRIDINE ANTIINFECTIVE AGENT [J].
COHEN, MA ;
HUBAND, MD ;
MAILLOUX, GB ;
YODER, SL ;
ROLAND, GE ;
DOMAGALA, JM ;
HEIFETZ, CL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (01) :141-146
[7]  
COHEN MA, 1992, 32ND INT C ANT AG CH
[8]  
FERNANDES CJ, 1992, 4TH INT S NEW QUIN
[9]   MULTICENTER EVALUATION OF THE INVITRO ACTIVITIES OF 3 NEW QUINOLONES, SPARFLOXACIN, CI-960, AND PD-131,628, COMPARED WITH THE ACTIVITY OF CIPROFLOXACIN AGAINST 5,252 CLINICAL BACTERIAL ISOLATES [J].
FUCHS, PC ;
BARRY, AL ;
PFALLER, MA ;
ALLEN, SD ;
GERLACH, EH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) :764-766
[10]  
Gilardi G. L., 1991, MANUAL CLIN MICROBIO